Synergy between vascular targeting agents and antibody-directed therapy (Q39636820)

13 September 2017

title

Synergy between vascular targeting agents and antibody-directed therapy (English)

1 reference

13 September 2017

1 reference

R Barbara Pedley

1

1 reference

13 September 2017

Ethaar El-Emir

2

1 reference

13 September 2017

Aiden A Flynn

3

1 reference

13 September 2017

Geoffrey M Boxer

4

1 reference

13 September 2017

Jason Dearling

5

1 reference

13 September 2017

James A Raleigh

6

1 reference

13 September 2017

Sally A Hill

7

1 reference

13 September 2017

Sam Stuart

8

1 reference

13 September 2017

Reeya Motha

9

1 reference

13 September 2017

Richard H J Begent

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

International Journal of Radiation Oncology Biology Physics

13 September 2017

published in

1 reference

13 September 2017

volume

54

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

1524-1531

1 reference

The next frontier of molecular medicine: delivery of therapeutics.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Clinical trials of antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Enhancement of radioimmunotherapy by drugs modifying tumour blood flow in a colonic xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Vascular Endothelium as the Vulnerable Element in Tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

The biology of the combretastatins as tumour vascular targeting agents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

The morphological effects of the anti-tumor agents flavone acetic acid and 5,6-dimethyl xanthenone acetic acid on the colon 38 mouse tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Targeting tumour vasculature: the development of combretastatin A4.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatomata

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

A computer program for comparing K samples with right-censored data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

Changes in tumor hypoxia measured with a double hypoxic marker technique

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903923-8

7 January 2021

10.1016/S0360-3016(02)03923-8

Identifiers

DOI

1 reference

13 September 2017

1 reference